Pancreatic Cancer Research

ResearcherUniversity of Florida HealthActive in the last 2 years

Daria Neyroud

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5886-802X; OpenAlex author ID A5049717010. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Local Inflammation Precedes Diaphragm Wasting and Fibrotic Remodelling in a Mouse Model of Pancreatic Cancer. Co-author DOI 10.1002/jcsm.13668↗
  2. Role of myofiber-specific FoxP1 in pancreatic cancer-induced muscle wasting. Co-author DOI 10.1152/ajpcell.00701.2024↗
  3. Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy. Co-author DOI 10.3390/cells11121893↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sarah M. Judge · 3 shared papers, 2022–2025 · strength 0.70
  2. Andrew R. Judge · 3 shared papers, 2022–2025 · strength 0.70
  3. Michael R. Deyhle · 2 shared papers, 2022–2025 · strength 0.42
  4. Chandler S. Callaway · 2 shared papers, 2022–2025 · strength 0.42
  5. Andrew C. D’Lugos · 2 shared papers, 2022–2025 · strength 0.42
  6. Martin M. Schonk · 1 shared paper, 2025 · strength 0.28
  7. Jeremy B. Ducharme · 1 shared paper, 2025 · strength 0.28
  8. Brittney Poole · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.